Quick Takeaways
- Patel Chintu filed SCHEDULE 13D/A for Amneal Pharmaceuticals, Inc. Class A Common Stock, par value $0.01 (AMRX).
- Disclosed ownership: 8.2%.
- Date of event: 03 Oct 2025.
Patel Chintu - 03 Oct 2025 SCHEDULE 13D/A Report for Amneal Pharmaceuticals, Inc. Class A Common Stock, par value $0.01 (AMRX)
- Filing Manager
- Patel Chintu
- Reporting Manager
- Patel Chintu
- Symbol
- AMRX
- Shares outstanding
- 315,976,000 shares
- Disclosed Ownership
- 25,910,032 shares
- Ownership
- 8.2%
- Form type
- SCHEDULE 13D/A
- Filing time
- 07 Oct 2025, 19:51:18 UTC
- Date of event
- 03 Oct 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Patel Chintu disclosed 8.2% ownership in Amneal Pharmaceuticals, Inc. Class A Common Stock, par value $0.01 (AMRX) on 03 Oct 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 07 Oct 2025, 19:51.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Patel Chintu | 8.2% | 25,910,032 | 25,910,032 | 0 | Chintu Patel | Patel Chintu | 0001737428 |